Herborium Group(HBRM)
$0.00-0.00 (-50.00%)
HBRM
Herborium Group financials statements
$0.00
At close:-0.00 (-50.00%)
Herborium Group (HBRM) Ratios
37 Followers
Herborium Group Ratios
HBRM's free cash flow for Q2 2024 was $-5.60K. For the 2024 fiscal year, HBRM's free cash flow was increased by $0.00 and operating cash flow was $-5.60K. See a summary of the company’s cash flow.
| Ratios | Nov 23 | Nov 22 | Nov 21 | Nov 20 | Nov 19 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.01 | 0.01 | 0.01 | 0.25 | 0.11 |
| Quick Ratio | 0.00 | 0.01 | 0.01 | 0.13 | 0.09 |
| Cash Ratio | 0.00 | 0.00 | 0.00 | 0.04 | 0.01 |
| Solvency Ratio | 0.04 | -0.06 | -0.08 | 0.07 | -0.10 |
| Operating Cash Flow Ratio | 0.10 | -0.04 | 0.03 | -0.13 | -0.16 |
| Short-Term Operating Cash Flow Coverage | 0.92 | -0.33 | 0.23 | -1.72 | -1.82 |
| Net Current Asset Value | $ -4.44M | $ -4.08M | $ -3.96M | $ -628.20K | $ -680.90K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 6.84 | 6.01 | 6.19 | 1.96 | 1.90 |
| Debt-to-Equity Ratio | -0.25 | -0.27 | -0.27 | -0.81 | -0.59 |
| Debt-to-Capital Ratio | -0.33 | -0.36 | -0.38 | -4.14 | -1.45 |
| Long-Term Debt-to-Capital Ratio | -0.18 | -0.20 | -0.20 | -3.08 | -1.09 |
| Financial Leverage Ratio | -0.04 | -0.04 | -0.04 | -0.41 | -0.31 |
| Debt Service Coverage Ratio | 0.49 | -0.65 | -0.64 | 2.95 | -0.79 |
| Interest Coverage Ratio | 0.00 | 0.00 | -6.97 | 0.00 | -2.45 |
| Debt to Market Cap | 99.57 | 0.54 | 0.24 | 0.63 | 0.51 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 5.36 | -3.95 | -3.71 | 5.24 | -6.73 |
| Profitability Margins | |||||
| Gross Profit Margin | 55.77% | 61.97% | 62.99% | 64.34% | 58.29% |
| EBIT Margin | 2.64% | -23.57% | -27.35% | 6.91% | -6.17% |
| EBITDA Margin | 17.64% | -23.17% | -26.78% | 7.52% | -5.49% |
| Operating Profit Margin | 2.57% | -23.57% | -27.35% | 6.91% | -6.17% |
| Pretax Profit Margin | 2.64% | -23.57% | -31.28% | 4.74% | -8.69% |
| Net Profit Margin | 2.64% | -23.57% | -31.28% | 4.74% | -8.69% |
| Continuous Operations Profit Margin | 2.64% | -23.57% | -31.28% | 4.74% | -8.69% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 102.80% | 100.00% | 114.35% | 68.56% | 140.74% |
| Return on Assets (ROA) | 18.89% | -152.51% | -193.39% | 22.81% | -43.93% |
| Return on Equity (ROE) | -0.68% | 6.75% | 8.57% | -9.36% | 13.68% |
| Return on Capital Employed (ROCE) | -0.79% | 8.08% | 9.03% | -55.76% | 20.31% |
| Return on Invested Capital (ROIC) | -0.88% | 9.19% | 10.33% | -70.17% | 23.80% |
| Return on Tangible Assets | 95.70% | -518.52% | -684.94% | 55.74% | -43.93% |
| Earnings Yield | 274.96% | -13.78% | -7.35% | 7.27% | -11.74% |
| Efficiency Ratios | |||||
| Receivables Turnover | 699.64 | 87.16 | 33.90 | 32.05 | 25.74 |
| Payables Turnover | 4.68 | 31.80 | 1.66 | 1.78 | 2.90 |
| Inventory Turnover | 30.94 | 19.59 | 64.83 | 9.58 | 45.63 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 7.16 | 6.47 | 6.18 | 4.81 | 5.06 |
| Working Capital Turnover Ratio | -0.31 | -0.34 | -0.59 | -3.11 | -3.38 |
| Cash Conversion Cycle | -65.65 | 11.35 | -202.98 | -154.99 | -103.82 |
| Days of Sales Outstanding | 0.52 | 4.19 | 10.77 | 11.39 | 14.18 |
| Days of Inventory Outstanding | 11.80 | 18.64 | 5.63 | 38.12 | 8.00 |
| Days of Payables Outstanding | 77.97 | 11.48 | 219.38 | 204.49 | 126.00 |
| Operating Cycle | 12.32 | 22.82 | 16.40 | 49.51 | 22.18 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.00 | -0.00 | 0.00 | -0.00 | -0.00 |
| Free Cash Flow Per Share | 0.00 | -0.00 | 0.00 | -0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | 199.98 | -83.31 | 2.24 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | 199.98 | -83.31 | 2.24 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | 0.35 | -0.13 | 0.09 | -0.11 | -0.22 |
| Operating Cash Flow to Sales Ratio | 0.33 | -0.12 | 0.09 | -0.04 | -0.08 |
| Free Cash Flow Yield | 3428.48% | -6.96% | 2.10% | -6.70% | -10.96% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 0.36 | -7.26 | -13.60 | 13.75 | -8.52 |
| Price-to-Sales (P/S) Ratio | 0.01 | 1.71 | 4.26 | 0.65 | 0.74 |
| Price-to-Book (P/B) Ratio | -0.00 | -0.49 | -1.17 | -1.29 | -1.17 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 0.03 | -14.36 | 47.53 | -14.92 | -9.12 |
| Price-to-Operating Cash Flow Ratio | 0.03 | -14.54 | 47.53 | -14.92 | -9.12 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 |
| Enterprise Value Multiple | 5.42 | -11.33 | -19.60 | 13.91 | -20.22 |
| Enterprise Value | 1.07M | 2.98M | 5.52M | 1.04M | 970.60K |
| EV to EBITDA | 5.42 | -11.33 | -19.60 | 13.91 | -20.22 |
| EV to Sales | 0.96 | 2.63 | 5.25 | 1.05 | 1.11 |
| EV to Free Cash Flow | 2.91 | -22.06 | 58.62 | -23.95 | -13.67 |
| EV to Operating Cash Flow | 2.89 | -22.33 | 58.62 | -23.95 | -13.67 |
| Tangible Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Shareholders’ Equity Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | 0.00 | -0.00 | -0.00 | 0.00 | -0.00 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.14 | 0.69 | 1.41 |
| Research & Development to Revenue | 0.03 | 0.03 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 12.53 | 0.50 | -0.29 | -0.92 | 0.93 |
Currency in USD

